Literature DB >> 25421520

Heavy alcohol use in lung donors increases the risk for primary graft dysfunction.

Erin M Lowery1, Erica A Kuhlmann, Erin L Mahoney, Daniel F Dilling, Stephanie A Kliethermes, Elizabeth J Kovacs.   

Abstract

BACKGROUND: Heavy alcohol use is known to increase the risk of acute lung injury and the acute respiratory distress syndrome. This is in part due to increased production of reactive oxygen species. We hypothesized that recipients of lungs from heavy drinkers would be more susceptible to lung injury following transplantation.
METHODS: In this retrospective cohort study, donor histories and transplant outcomes were reviewed in 192 consecutive lung transplant recipients. Donors were classified as No Alcohol Use, Moderate Alcohol Use, or Heavy Alcohol Use based on documented donor histories.
RESULTS: Freedom from mechanical ventilation took longer in the lung transplant recipients whose donors had Heavy Alcohol Use, compared with those whose donors had No Alcohol Use or Moderate Alcohol Use (p = 0.01). At admission to the intensive care unit, the Heavy Alcohol Use group had median PaO2 /FiO2 ratio 219 (interquartile range [IQR]: 162 to 382), compared with 305 (IQR: 232 to 400) in the Moderate Alcohol Use group and 314 (IQR: 249 to 418) in the No Alcohol Use group (p = 0.005). The odds of developing severe primary graft dysfunction (PGD) in the Heavy Alcohol Use group versus the No Alcohol Use group were 8.7 times greater (95% confidence interval 1.427 to 53.404, p = 0.019) after controlling for factors known to be associated with PGD.
CONCLUSIONS: Recipients of donors with a heavy alcohol use history had an over 8 times greater risk of developing severe PGD following lung transplant. The increase in PGD resulted in poorer gas exchange in the recipients of donor lungs from heavy alcohol users, and these recipients subsequently required mechanical ventilation for a longer time following transplant. Further investigation into lung donors with heavy alcohol use histories is necessary to determine those at highest risk for PGD following transplant.
Copyright © 2014 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; Lung; Lung Transplant; Primary Graft Dysfunction

Mesh:

Year:  2014        PMID: 25421520      PMCID: PMC4263285          DOI: 10.1111/acer.12553

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  31 in total

1.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

2.  Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome.

Authors:  Shih-jui Lin; James K Koford; Bradley C Baird; John F Hurdle; Sergey Krikov; Arsalan N Habib; Alexander S Goldfarb-Rumyantzev
Journal:  Transplantation       Date:  2005-08-27       Impact factor: 4.939

3.  The effect of primary graft dysfunction on survival after lung transplantation.

Authors:  Jason D Christie; Robert M Kotloff; Vivek N Ahya; Gregory Tino; Alberto Pochettino; Christina Gaughan; Ejigayehu DeMissie; Stephen E Kimmel
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

4.  Tobacco and alcohol use in lung transplant candidates and recipients.

Authors:  Donna M Evon; Eileen J Burker; Jan A Sedway; R Cicale; K Davis; T Egan
Journal:  Clin Transplant       Date:  2005-04       Impact factor: 2.863

5.  The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.

Authors:  D Sorbi; J Boynton; K D Lindor
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

6.  Alcohol use in donors is a protective factor on recipients' outcome after heart transplantation.

Authors:  David J De La Zerda; Oved Cohen; Ramin E Beygui; John Kobashigawa; Diana Hekmat; Hillel Laks
Journal:  Transplantation       Date:  2007-05-15       Impact factor: 4.939

7.  The influence of donor characteristics on survival after heart transplantation.

Authors:  C I Tsao; R J Chen; N K Chou; W J Ko; N H Chi; H Y Yu; Y S Chen; S C Chen; S S Wang
Journal:  Transplant Proc       Date:  2008-10       Impact factor: 1.066

8.  The AUDIT alcohol consumption questions: reliability, validity, and responsiveness to change in older male primary care patients.

Authors:  K A Bradley; M B McDonell; K Bush; D R Kivlahan; P Diehr; S D Fihn
Journal:  Alcohol Clin Exp Res       Date:  1998-11       Impact factor: 3.455

9.  High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.

Authors:  H Nyblom; U Berggren; J Balldin; R Olsson
Journal:  Alcohol Alcohol       Date:  2004 Jul-Aug       Impact factor: 2.826

10.  Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics.

Authors:  G M Jong; T R Hsiue; C R Chen; H Y Chang; C W Chen
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

View more
  9 in total

1.  Recent alcohol use prolongs hospital length of stay following lung transplant.

Authors:  Erin M Lowery; Meagan Yong; Arala Cohen; Cara Joyce; Elizabeth J Kovacs
Journal:  Clin Transplant       Date:  2018-06-20       Impact factor: 2.863

Review 2.  Summary of the 2018 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Paulius V Kuprys; Hidekazu Tsukamoto; Bin Gao; Lin Jia; Jacob McGowan; Craig M Coopersmith; Maria Camargo Moreno; Holly Hulsebus; Avtar S Meena; Flavia M Souza-Smith; Philip Roper; Michelle T Foster; S Vamsee Raju; S Alex Marshall; Mayumi Fujita; Brenda J Curtis; Todd A Wyatt; Pranoti Mandrekar; Elizabeth J Kovacs; Mashkoor A Choudhry
Journal:  Alcohol       Date:  2018-08-24       Impact factor: 2.405

3.  Risk factors and outcome of primary graft dysfunction after lung transplantation in Korea.

Authors:  Sungwoo Moon; Moo Suk Park; Jin Gu Lee; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Joon Chang; Hyo Chae Paik; Song Yee Kim
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury.

Authors:  Ciara M Shaver; Nancy Wickersham; J Brennan McNeil; Hiromasa Nagata; Adam Miller; Stuart R Landstreet; Jamie L Kuck; Joshua M Diamond; David J Lederer; Steven M Kawut; Scott M Palmer; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria M Crespo; Jonathan B Orens; Pali D Shah; Chadi A Hage; Edward Cantu; Mary K Porteous; Gundeep Dhillon; John McDyer; Julie A Bastarache; Jason D Christie; Lorraine B Ware
Journal:  JCI Insight       Date:  2018-01-25

5.  Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37.

Authors:  M Camargo Moreno; J B Lewis; E J Kovacs; E M Lowery
Journal:  Alcohol       Date:  2018-11-09       Impact factor: 2.405

6.  Use of alcohol biomarkers to identify alcohol misuse in organ donors.

Authors:  Erin M Lowery; Martin Walsh; Meagan Yong; Elizabeth J Kovacs; Cara Joyce; Majid Afshar
Journal:  Alcohol       Date:  2018-03-31       Impact factor: 2.405

Review 7.  Pathophysiology and classification of primary graft dysfunction after lung transplantation.

Authors:  Morvern Isabel Morrison; Thomas Leonard Pither; Andrew John Fisher
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Impact of alcohol use on 30-day complication and readmission rates after elective spinal fusion (≥2 levels) for adult spine deformity: a single institutional study of 1,010 patients.

Authors:  Aladine A Elsamadicy; Owoicho Adogwa; Victoria D Vuong; Amanda Sergesketter; Gireesh Reddy; Joseph Cheng; Carlos A Bagley; Isaac O Karikari
Journal:  J Spine Surg       Date:  2017-09

9.  Early Graft Dysfunction after Lung Transplantation.

Authors:  Justin Rosenheck; Colleen Pietras; Edward Cantu
Journal:  Curr Pulmonol Rep       Date:  2018-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.